gabexate has been researched along with Anesthesia in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To test the hypothesis that gabexate mesilate, a protease inihibitor, hastens recovery from neuromuscular blockade, we examined the effect of gabexate mesilate on the recovery of vecuronium-induced neuromuscular blockade in anaesthetized patients in a double-blind, randomized fashion." | 9.11 | Gabexate mesilate hastens recovery from vecuronium-induced neuromuscular blockade. ( Akatu, M; Hattori, H; Murakawa, M; Nakajima, H; Saitoh, Y; Sanbe, N, 2005) |
| " The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia." | 7.76 | [Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010) |
| "To test the hypothesis that gabexate mesilate, a protease inihibitor, hastens recovery from neuromuscular blockade, we examined the effect of gabexate mesilate on the recovery of vecuronium-induced neuromuscular blockade in anaesthetized patients in a double-blind, randomized fashion." | 5.11 | Gabexate mesilate hastens recovery from vecuronium-induced neuromuscular blockade. ( Akatu, M; Hattori, H; Murakawa, M; Nakajima, H; Saitoh, Y; Sanbe, N, 2005) |
| " The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia." | 3.76 | [Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T | 1 |
| Kurahashi, K | 1 |
| Goto, T | 1 |
| Hattori, H | 1 |
| Saitoh, Y | 1 |
| Nakajima, H | 1 |
| Sanbe, N | 1 |
| Akatu, M | 1 |
| Murakawa, M | 1 |
1 trial available for gabexate and Anesthesia
| Article | Year |
|---|---|
Gabexate mesilate hastens recovery from vecuronium-induced neuromuscular blockade.
Topics: Adult; Aged; Anesthesia; Anesthesia Recovery Period; Electric Stimulation; Female; Gabexate; Hemodyn | 2005 |
1 other study available for gabexate and Anesthesia
| Article | Year |
|---|---|
[Case of hyperkalemia possibly caused by gabexate mesilate].
Topics: Anesthesia; Female; Gabexate; Humans; Hyperkalemia; Intraoperative Complications; Liver Transplantat | 2010 |